{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T10:32:58Z","timestamp":1724668378396},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s00063-022-00984-8","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T13:02:54Z","timestamp":1673528574000},"page":"14-20","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Thrombotische Mikroangiopathien"],"prefix":"10.1007","volume":"118","author":[{"given":"Tilman","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias B.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"984_CR1","doi-asserted-by":"crossref","unstructured":"Amorosi\u00a0EL, Ultmann\u00a0JE (1966) Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine 45(2):139\u2013160","DOI":"10.1097\/00005792-196603000-00003"},{"key":"984_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1681\/ASN.2013050453","volume":"25","author":"F Bu","year":"2014","unstructured":"Bu\u00a0F, Maga\u00a0T, Meyer\u00a0NC et\u00a0al (2014) Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome. J\u00a0Am Soc Nephrol 25:55\u201364. https:\/\/doi.org\/10.1681\/ASN.2013050453","journal-title":"J. Am. Soc. Nephrol."},{"key":"984_CR3","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.amjmed.2015.05.048","volume":"128","author":"N Chhabra","year":"2015","unstructured":"Chhabra\u00a0N, Lee\u00a0S, Sakalis\u00a0EG (2015) Cobalamin deficiency causing severe hemolytic anemia: a pernicious presentation. Am J Med 128:e5\u2013e6. https:\/\/doi.org\/10.1016\/j.amjmed.2015.05.048","journal-title":"Am J Med"},{"key":"984_CR4","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.3324\/haematol.2019.216796","volume":"104","author":"HA van Dorland","year":"2019","unstructured":"van Dorland\u00a0HA, Taleghani\u00a0MM, Sakai\u00a0K et\u00a0al (2019) The international hereditary thrombotic thrombocytopenic purpura registry: key findings at enrollment until 2017. Haematologica 104:2107\u20132115. https:\/\/doi.org\/10.3324\/haematol.2019.216796","journal-title":"Haematologica"},{"key":"984_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.pcad.2006.02.004","volume":"48","author":"WJ Elliott","year":"2006","unstructured":"Elliott\u00a0WJ (2006) Clinical features in the management of selected hypertensive emergencies. Prog Cardiovasc Dis 48:316\u2013325. https:\/\/doi.org\/10.1016\/j.pcad.2006.02.004","journal-title":"Prog Cardiovasc Dis"},{"key":"984_CR6","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","volume":"358","author":"V Eremina","year":"2008","unstructured":"Eremina\u00a0V, Jefferson\u00a0JA, Kowalewska\u00a0J et\u00a0al (2008) VEGF inhibition and renal thrombotic microangiopathy. N\u00a0Engl J Med 358:1129\u20131136. https:\/\/doi.org\/10.1056\/NEJMoa0707330","journal-title":"N Engl J Med"},{"key":"984_CR7","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1056\/NEJMra0801082","volume":"359","author":"B Furie","year":"2008","unstructured":"Furie\u00a0B, Furie\u00a0BC (2008) Mechanisms of thrombus formation. N\u00a0Engl J Med 359:938\u2013949. https:\/\/doi.org\/10.1056\/NEJMra0801082","journal-title":"N Engl J Med"},{"key":"984_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1056\/NEJMcps1606750","volume":"376","author":"JN George","year":"2017","unstructured":"George\u00a0JN, Morton\u00a0JM, Liles\u00a0NW, Nester\u00a0CM (2017) After the party\u2019s over. N\u00a0Engl J Med 376:74\u201380. https:\/\/doi.org\/10.1056\/NEJMcps1606750","journal-title":"N Engl J Med"},{"key":"984_CR9","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1056\/NEJMra1312353","volume":"371","author":"JN George","year":"2014","unstructured":"George\u00a0JN, Nester\u00a0CM (2014) Syndromes of thrombotic microangiopathy. N\u00a0Engl J Med 371:654\u2013666. https:\/\/doi.org\/10.1056\/NEJMra1312353","journal-title":"N Engl J Med"},{"key":"984_CR10","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1161\/CIRCULATIONAHA.115.015721","volume":"132","author":"A Goel","year":"2015","unstructured":"Goel\u00a0A, Maski\u00a0MR, Bajracharya\u00a0S et\u00a0al (2015) Epidemiology and mechanisms of de novo and persistent hypertension in the postpartum period. Circulation 132:1726\u20131733. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.015721","journal-title":"Circulation"},{"key":"984_CR11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","volume":"91","author":"THJ Goodship","year":"2017","unstructured":"Goodship\u00a0THJ, Cook\u00a0HT, Fakhouri\u00a0F et\u00a0al (2017) Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a\u00a0\u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference. Kidney Int 91:539\u2013551. https:\/\/doi.org\/10.1016\/j.kint.2016.10.005","journal-title":"Kidney Int"},{"key":"984_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/00001721-199703000-00001","volume":"8","author":"SG Gordon","year":"1997","unstructured":"Gordon\u00a0SG, Mielicki\u00a0WP (1997) Cancer procoagulant: a\u00a0factor X activator, tumor marker and growth factor from malignant tissue. Blood Coagul Fibrinol Int J Haemost Thromb 8:73\u201386","journal-title":"Blood Coagul Fibrinol Int J Haemost Thromb"},{"key":"984_CR13","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0140-6736(15)00076-8","volume":"386","author":"S Grang\u00e9","year":"2015","unstructured":"Grang\u00e9\u00a0S, Bekri\u00a0S, Artaud-Macari\u00a0E et al (2015) Adult-onset renal thrombotic microangiopathy and pulmonary arterial hypertension in cobalamin C deficiency. Lancet 386:1011\u20131012. https:\/\/doi.org\/10.1016\/S0140-6736(15)00076-8","journal-title":"Lancet"},{"key":"984_CR14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.thromres.2013.12.031","volume":"133","author":"M Hellum","year":"2014","unstructured":"Hellum\u00a0M, \u00d8vsteb\u00f8\u00a0R, Brusletto\u00a0BS et al (2014) Microparticle-associated tissue factor activity correlates with plasma levels of bacterial lipopolysaccharides in meningococcal septic shock. Thromb Res 133:507\u2013514. https:\/\/doi.org\/10.1016\/j.thromres.2013.12.031","journal-title":"Thromb Res"},{"key":"984_CR15","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","volume":"368","author":"CM Legendre","year":"2013","unstructured":"Legendre\u00a0CM, Licht\u00a0C, Muus\u00a0P et\u00a0al (2013) Terminal complement inhibitor eculizumab in atypical hemolytic\u2013uremic syndrome. N\u00a0Engl J Med 368:2169\u20132181. https:\/\/doi.org\/10.1056\/NEJMoa1208981","journal-title":"N Engl J Med"},{"key":"984_CR16","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ki.2014.423","volume":"87","author":"C Licht","year":"2015","unstructured":"Licht\u00a0C, Greenbaum\u00a0LA, Muus\u00a0P et al (2015) Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2\u2011year extensions of phase 2\u00a0studies. Kidney Int 87:1061\u20131073. https:\/\/doi.org\/10.1038\/ki.2014.423","journal-title":"Kidney Int"},{"key":"984_CR17","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1182\/asheducation-2013.1.675","volume":"2013","author":"W Lim","year":"2013","unstructured":"Lim\u00a0W (2013) Antiphospholipid syndrome. Hematol Am Soc Hematol Educ Program 2013:675\u2013680. https:\/\/doi.org\/10.1182\/asheducation-2013.1.675","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"984_CR18","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"SE Maynard","year":"2003","unstructured":"Maynard\u00a0SE, Min\u00a0J\u2011Y, Merchan\u00a0J et al (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J\u00a0Clin Invest 111:649\u2013658. https:\/\/doi.org\/10.1172\/JCI17189","journal-title":"J Clin Invest"},{"key":"984_CR19","series-title":"GeneReviews\u00ae","volume-title":"Genetic atypical hemolytic-uremic syndrome","author":"M Noris","year":"1993","unstructured":"Noris\u00a0M, Bresin\u00a0E, Mele\u00a0C, Remuzzi\u00a0G (1993) Genetic atypical hemolytic-uremic syndrome. GeneReviews\u00ae"},{"key":"984_CR20","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1056\/NEJMcp1901117","volume":"381","author":"AJ Peixoto","year":"2019","unstructured":"Peixoto\u00a0AJ (2019) Acute severe hypertension. N\u00a0Engl J Med 381:1843\u20131852. https:\/\/doi.org\/10.1056\/NEJMcp1901117","journal-title":"N Engl J Med"},{"key":"984_CR21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1505533","volume":"374","author":"F Peyvandi","year":"2016","unstructured":"Peyvandi\u00a0F, Scully\u00a0M, Kremer Hovinga\u00a0JA et\u00a0al (2016) Caplacizumab for acquired thrombotic thrombocytopenic purpura. N\u00a0Engl J Med 374:511\u2013522. https:\/\/doi.org\/10.1056\/NEJMoa1505533","journal-title":"N Engl J Med"},{"key":"984_CR22","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJMoa1106920","volume":"365","author":"DA Rasko","year":"2011","unstructured":"Rasko\u00a0DA, Webster\u00a0DR, Sahl\u00a0JW et\u00a0al (2011) Origins of the E. coli strain causing an outbreak of hemolytic\u2013uremic syndrome in Germany. N\u00a0Engl J Med 365:709\u2013717. https:\/\/doi.org\/10.1056\/NEJMoa1106920","journal-title":"N Engl J Med"},{"key":"984_CR23","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1182\/blood-2017-04-636431","volume":"130","author":"JE Sadler","year":"2017","unstructured":"Sadler\u00a0JE (2017) Pathophysiology of thrombotic thrombocytopenic purpura. Blood 130:1181\u20131188. https:\/\/doi.org\/10.1182\/blood-2017-04-636431","journal-title":"Blood"},{"key":"984_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1056\/NEJMoa1806311","volume":"380","author":"M Scully","year":"2019","unstructured":"Scully\u00a0M, Cataland\u00a0SR, Peyvandi\u00a0F et\u00a0al (2019) Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura. N\u00a0Engl J Med 380:335\u2013346. https:\/\/doi.org\/10.1056\/NEJMoa1806311","journal-title":"N Engl J Med"},{"key":"984_CR25","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1001\/jama.280.6.559","volume":"280","author":"JH Stone","year":"1998","unstructured":"Stone\u00a0JH (1998) HELLP syndrome: hemolysis, elevated liver enzymes, and low platelets. JAMA 280:559\u2013562. https:\/\/doi.org\/10.1001\/jama.280.6.559","journal-title":"JAMA"},{"key":"984_CR26","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/ajh\/2.6.486","volume":"2","author":"S Strandgaard","year":"1989","unstructured":"Strandgaard\u00a0S, Paulson\u00a0OB (1989) Cerebral blood flow and its pathophysiology in hypertension. Am J Hypertens 2:486\u2013492. https:\/\/doi.org\/10.1093\/ajh\/2.6.486","journal-title":"Am J Hypertens"},{"key":"984_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1542\/pir.2018-0346","volume":"41","author":"B Viteri","year":"2020","unstructured":"Viteri\u00a0B, Saland\u00a0JM (2020) Hemolytic uremic syndrome. Pediatr Rev 41:213\u2013215. https:\/\/doi.org\/10.1542\/pir.2018-0346","journal-title":"Pediatr Rev"},{"key":"984_CR28","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1182\/bloodadvances.2020001973","volume":"4","author":"LA V\u00f6lker","year":"2020","unstructured":"V\u00f6lker\u00a0LA, Kaufeld\u00a0J, Miesbach\u00a0W et al (2020) Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura. Blood Adv 4:3085\u20133092. https:\/\/doi.org\/10.1182\/bloodadvances.2020001973","journal-title":"Blood Adv"},{"key":"984_CR29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/01.AOG.0000249609.04831.7c","volume":"109","author":"M Widmer","year":"2007","unstructured":"Widmer\u00a0M, Villar\u00a0J, Benigni\u00a0A et\u00a0al (2007) Mapping the theories of preeclampsia and the role of angiogenic factors: a\u00a0systematic review. Obstet Gynecol 109:168\u2013180. https:\/\/doi.org\/10.1097\/01.AOG.0000249609.04831.7c","journal-title":"Obstet Gynecol"},{"key":"984_CR30","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1055\/s-2005-925474","volume":"31","author":"A Zakarija","year":"2005","unstructured":"Zakarija\u00a0A, Bennett\u00a0C (2005) Drug-induced thrombotic microangiopathy. Semin Thromb Hemost 31:681\u2013690. https:\/\/doi.org\/10.1055\/s-2005-925474","journal-title":"Semin Thromb Hemost"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-022-00984-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00063-022-00984-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-022-00984-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T11:05:06Z","timestamp":1674558306000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00063-022-00984-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["984"],"URL":"https:\/\/doi.org\/10.1007\/s00063-022-00984-8","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]},"assertion":[{"value":"19 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"T.\u00a0Schmidt berichtet\u00a0von Vereinbarungen mit Alexion\u00a0und Novartis. T.B.\u00a0Huber berichtet von Vereinbarungen mit Alexion, AstraZeneca, Bayer, Boehringer-Ingelheim, DaVita, Fresenius Medical Care, Novartis, Pfizer, Retrophin-Travere, Vifor,\u00a0Amicus Therapeutics und\u00a0Fresenius Medical Care.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}